Week 1 Peds Therapeutics Flashcards
Limitations to off-label drug usage
- potential for denied insurance coverage
- liability for adverse effects
- limited experience in specific conditions or age groups
- limited available dosage formulations
How to ensure efficacy when using med off-label
use guidelines snd use primary literature
Strategies to improve adherence
- caregiver edu
- ease of admin (palatability and dec frequency)
- dec child resistance
- empowering older children/adolescents
Water containing formulations BUD
14 days when refrigerated
when is it okay to give injectable solutions as oral formulation
ok if iv and po formulations have same salt form w/ similar bioavailability
what is the maximum pediatric dose usually
the adult dose
what should you always ask for when determining pediatric drug dosage
weight
units for GFR in and out
in= ml/kg/day
out= ml/kg/hr
Urine assessment anuria, oliguria, normal urine outpt, polyuria
anuria= zero output
oliguria <.5-1 ml/kg/hr
normal UO >1 ml/kg/hr
polyuria >4ml/kg/hr
what happens to the pH of infants
higher gastric pH (more basic)
what happens to the gastric emptying of newborns vs infants
- higher rates during first week of life (newborn) leads to more drug delivery to site of absorption
- infants have reduced rates of contractions and gastric emptying leads to dec dru absorption
what is rectal absorption like in infants
more stools, dec time drug is able to be absorbed, decreased bioavailability
what is percutaneous (blood vessel) absorption like in infants
greater degree of hydration and higher perfusion rates= enhanced drug permeability
what is IM absorption like in infants
inc capillary density (more drug in blood stream) = inc IM bioavailability
what is distribution like in infants
inc Vd of hydrophilic drugs (ex. aminoglycosides), dec Vd of lipophilic drugs
what is protein binding like in infants, what drugs to avoid
- dec protein binding of fetal albumin = more free drug
- avoid ceftrixone and sulfonamides in infants 2 months and younger
what should happen to dosing of CYP2C19 drugs if pt is 3 months old and why?
Inc dose
CYPC19 metabolism increased during first 6 months of life then normalizes. ex Omeprazole
when do infants develop CYP3A4 mature metabolism
1 year. starts as 3A7 then turns to 3A4
overall trend of metabolism/ enzymes in newborns/children
Enzyme activity increases w/ time. UGT matures earlier than other enzymes
Pearls about Phase 2 metabolism of Acetaminophen in children less than 12
Infants have protection against APAP toxicity as the primary phase 2 metabolism is sulfation instead of glucoronidation. Therefore they wont of over saturation
when does complete nephrogenesis (kidney) develop
36 weeks
8 months
Elimination implications for drug dose
due to dec renal BF & GFR
- Slower drug clearance
- longer drug half-life
- requires less frequent dosing
How frequent should dosing of antibiotics be for a pt who is <29 weeks gestation and born < 14 days ago
every 72 hours
How frequent should dosing of antibiotics be for a pt who is <29 weeks gestation and born > 14 days ago
every 48 hours